Textilinins from Pseudonaja textilis textilis.: Characterization of two plasmin inhibitors that reduce bleeding in an animal model

被引:70
作者
Masci, PP
Whitaker, AN
Sparrow, LG
de Jersey, J
Winzor, DJ
Watters, DJ
Lavin, MF
Gaffney, PJ
机构
[1] Univ Queensland, Princess Alexandra Hosp, Dept Med, Woolloongabba, Qld, Australia
[2] CSIRO Biomol Engn, Parkville Lab, Parkville, Vic, Australia
[3] Univ Queensland, Dept Biochem, St Lucia, Qld, Australia
[4] Queensland Inst Med Res, Herston, Qld 4006, Australia
[5] Natl Inst Biol Stand & Controls, S Mimms, Herts, England
关键词
textilinin; antifibrinolytic agent; plasmin inhibitor; Kunitz-type; reduce bleeding; Pseudonaja textilis textilis;
D O I
10.1097/00001721-200006000-00011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The incidence of vein-graft occlusion associated with myocardial infarction and thrombosis following the use of the plasmin inhibitor, aprotinin, to reduce blood loss during vascular surgery has prompted the isolation of an alternative kinetically distinct inhibitor of plasmin from the venom of Pseudonaja textilis. This inhibitor has been called textilinin (Txln) and two distinct forms have been isolated from the Brown-snake venom (molecular weight, 6688 and 6692). A comparison of plasmin inhibitor constants for aprotinin and the Txlns 1 and 2 indicated that the former bound very tightly (inhibitor constant, K-i approximate to 10(-11) mol/l), while both of the latter bound less tightly (K-i approximate to 10(-9) mol/l). Homogeneity of Txlns 1 and 2 was confirmed by sodium dodecyl sulphate-polyacrylamide gel electrophoresis and mass spectrometry. A sequence difference of six amino acids was observed between the two forms of Txln. Txln 1 and 2 showed, respectively, 45 and 43% homology with aprotinin, while there was 58 and 55% homology, respectively, with a plasmin inhibitor from the venom of eastern Taipan, Oxyuranus scurellatus. Both Txlns have six cysteines, like other inhibitors of this group, and homology was determined by alignment of these cysteines. Both have been shown to reduce blood loss by about 60% in a murine tail vein bleeding model. It is proposed that the kinetic profiles of Txln 1 and 2 for plasmin allow the arrest of haemorrhage without the possible threat of thrombosis. Blood Coagul Fibrinolysis 11:385-393 (C) 2000 Lippincott Williams & Wilkins.
引用
收藏
页码:385 / 393
页数:9
相关论文
共 41 条
[1]  
COOPER BE, 1995, J PHARM SCI TECHNOL, V611, P156
[2]   APROTININ THERAPY FOR REOPERATIVE MYOCARDIAL REVASCULARIZATION - A PLACEBO-CONTROLLED STUDY [J].
COSGROVE, DM ;
HERIC, B ;
LYTLE, BW ;
TAYLOR, PC ;
NOVOA, R ;
GOLDING, LAR ;
STEWART, RW ;
MCCARTHY, PM ;
LOOP, FD .
ANNALS OF THORACIC SURGERY, 1992, 54 (06) :1031-1038
[3]   PLASMINOGEN - PURIFICATION FROM HUMAN PLASMA BY AFFINITY CHROMATOGRAPHY [J].
DEUTSCH, DG ;
MERTZ, ET .
SCIENCE, 1970, 170 (3962) :1095-+
[4]   FATAL ANAPHYLACTIC SHOCK AFTER APROTININ REEXPOSURE IN CARDIAC-SURGERY [J].
DIEFENBACH, C ;
ABEL, M ;
LIMPERS, B ;
LYNCH, J ;
RUSKOWSKI, H ;
JUGERT, FK ;
BUZELLO, W .
ANESTHESIA AND ANALGESIA, 1995, 80 (04) :830-831
[5]   INFLUENCE OF HIGH-DOSE APROTININ TREATMENT ON BLOOD-LOSS AND COAGULATION PATTERNS IN PATIENTS UNDERGOING MYOCARDIAL REVASCULARIZATION [J].
DIETRICH, W ;
SPANNAGL, M ;
JOCHUM, M ;
WENDT, P ;
SCHRAMM, W ;
BARANKAY, A ;
SEBENING, F ;
RICHTER, JA .
ANESTHESIOLOGY, 1990, 73 (06) :1119-1126
[6]  
FRIBERGER P, 1978, HAEMOSTASIS, V7, P138
[7]  
FRITZ H, 1983, DRUG RES ARNZEIMITTE, V4, P479
[8]   STRUCTURAL ASPECT OF HUMAN FIBRINOGEN SUGGESTED BY ITS PLASMIN DEGRADATION [J].
GAFFNEY, PJ ;
DOBOS, P .
FEBS LETTERS, 1971, 15 (01) :13-&
[9]  
GAFFNEY PJ, 1997, RECENT PROGR BLOOD C, P27
[10]  
GURDETTI B, 1981, SURG NEUROL, V15, P239